Petmed Express Inc (PETS) Releases Earnings Results, Beats Expectations By $0.02 EPS

Petmed Express Inc (PETS) reported quarterly earnings results on Monday, May-9-2016. The company said it had a profit of $0.27 Earnings per Share for the quarter. The results exceeded Wall Street expectations beating the analyst consensus estimate by $0.02. Analysts had a consensus of $0.25. The company posted revenue of $55.39 million in the period, compared to analysts expectations of $50.22 million. The company’s revenue was up 10.8% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.25 EPS.

Petmed Express Inc opened for trading at $17.92 and hit $18.95 on the upside on Friday, eventually ending the session at $18.75, with a gain of 4.46% or 0.8 points. The heightened volatility saw the trading volume jump to 4,87,612 shares. Company has a market cap of $381 M.

In a different news, on Mar 15, 2016, Bruce S Rosenbloom (CHIEF FINANCIAL OFFICER) sold 3,000 shares at $17.25 per share price. According to the SEC, on Feb 23, 2016, Ronald J Korn (director) sold 5,000 shares at $16.76 per share price. On Jun 22, 2015, Menderes Akdag (CEO & President) sold 8,000 shares at $17.75 per share price, according to the Form-4 filing with the securities and exchange commission.

PetMed Express Inc. (PetMed Express) doing business as 1800PetMeds is a pet pharmacy. The Company markets prescription and non-prescription pet medications and other health products for dogs and cats direct to the consumer. The Company offers a selection of products for dogs and cats. The Company’s product line contains approximately 3000 stock keeping units (SKUS) of pet medications health products and supplies. These products include brands of medication such as Frontline Plus K9 Advantix II Advantage II Heartgard Plus Sentinel Revolution and Rimadyl. It also offers for sale additional pet supplies on its Website which are drop shipped to its customers by third party vendors. These pet supplies include food beds crates stairs strollers and other pet supplies. The Company’s products included Non-Prescription Medications (Over the Counter (OTC)) and supplies and Prescription Medications (Rx).

Petmed Express Inc

Leave a Reply

Petmed Express Inc - Is it time to Sell?

Top Brokerage Firms are advising their investors on Petmed Express Inc. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.